Scitara

Scitara

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $51.5M

Overview

Scitara operates in the digital health and AI/ML sectors, offering a specialized iPaaS solution for modernizing laboratory operations. The company's DLX platform enables labs to connect disparate instruments and informatics systems, automate manual data workflows with low/no-code tools, and monitor all data movements for compliance and integrity. Targeting R&D, bioprocessing, and quality control labs in pharmaceutical and other process-based industries, Scitara aims to drive efficiency, reduce errors, and unlock data for advanced analytics and AI initiatives.

Digital HealthAI / Machine Learning

Technology Platform

Scitara DLX, a cloud-based, laboratory-specific Integration Platform as a Service (iPaaS). It provides pre-built connectors for lab instruments and systems, a no/low-code workflow orchestration editor, and a monitoring console for data integrity and compliance.

Funding History

3
Total raised:$51.5M
Series B$35M
Series A$13M
Seed$3.5M

Opportunities

The rapid digital transformation of labs under Pharma 4.0 and the need for clean, integrated data to fuel AI/ML initiatives present a massive growth opportunity.
Expansion from core pharma/QC labs into adjacent sectors like bioprocessing, materials science, and academia offers additional market potential.

Risk Factors

Competition from large informatics vendors with bundled suites and general-purpose iPaaS providers poses a significant threat.
Long enterprise sales cycles in regulated industries and the continuous need to develop and maintain a vast library of instrument connectors present execution and resource challenges.

Competitive Landscape

Scitara competes with large laboratory informatics vendors (e.g., Thermo Fisher, LabVantage) that offer proprietary, but often closed, integration within their own ecosystems, and with general-purpose enterprise iPaaS players (e.g., MuleSoft, Boomi) that lack deep domain expertise in laboratory workflows and compliance requirements. Its differentiation lies in its lab-specific focus, vendor-agnostic connectivity, and composable architecture.